![René Douville](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
René Douville
Directeur/Membre du Conseil chez
Montréal International
Profil
René Douville is currently the Director at Montréal International, Director at Univalor, Inc., and Principal at Montréal Heart Institute.
He previously worked as the Director-National Client Group at RBC Dominion Securities, Inc., Director at Genome Canada, Director at BIOTECanada, and Board Member at Foragen Technologies Management, Inc. He was also the Managing Partner at RBC Technology Ventures, Inc. from 1997 to 2008.
Mr. Douville completed his undergraduate degree at McGill University.
Postes actifs de René Douville
| Sociétés | Poste | Début |
|---|---|---|
Montréal Heart Institute
 Montréal Heart Institute Miscellaneous Commercial ServicesCommercial Services Operates as a organization for heart disease education | Corporate Officer/Principal | 22/06/2011 |
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Directeur/Membre du Conseil | 28/06/2018 |
Montréal International
 Montréal International Miscellaneous Commercial ServicesCommercial Services Attracts and promotes economic development of Greater Montreal | Directeur/Membre du Conseil | - |
Anciens postes connus de René Douville
| Sociétés | Poste | Fin |
|---|---|---|
Foragen Technologies Management, Inc.
 Foragen Technologies Management, Inc. Investment ManagersFinance Foragen Technologies Management invests in seed and early-stage, advanced agricultural technologies in Canada. | Corporate Officer/Principal | 30/04/2009 |
RBC Technology Ventures, Inc.
 RBC Technology Ventures, Inc. Investment ManagersFinance RBC Technology Ventures specializes in investments in technology for the financial services industry and financial services enabled by technology. The firm considers investment opportunities throughout North America. They often syndicate their investments with other financial investors who will actively participate in the growth and development of the company. Initial investments typically range from $4 million to $6 million. RBC Technology Ventures actively participates on their portfolio companies' boards of directors. | Private Equity Investor | 30/11/2008 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | - |
RBC Dominion Securities, Inc.
 RBC Dominion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Directeur/Membre du Conseil | - |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Directeur/Membre du Conseil | - |
Formation de René Douville
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
RBC Dominion Securities, Inc.
RBC Dominion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foragen Technologies Management, Inc.
Foragen Technologies Management, Inc. Investment ManagersFinance Foragen Technologies Management invests in seed and early-stage, advanced agricultural technologies in Canada. | Finance |
RBC Technology Ventures, Inc.
RBC Technology Ventures, Inc. Investment ManagersFinance RBC Technology Ventures specializes in investments in technology for the financial services industry and financial services enabled by technology. The firm considers investment opportunities throughout North America. They often syndicate their investments with other financial investors who will actively participate in the growth and development of the company. Initial investments typically range from $4 million to $6 million. RBC Technology Ventures actively participates on their portfolio companies' boards of directors. | Finance |
Montréal International
Montréal International Miscellaneous Commercial ServicesCommercial Services Attracts and promotes economic development of Greater Montreal | Commercial Services |
Genome Canada
Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Commercial Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Univalor, Inc.
Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Commercial Services |
Montréal Heart Institute
Montréal Heart Institute Miscellaneous Commercial ServicesCommercial Services Operates as a organization for heart disease education | Commercial Services |
